Barry Flannelly
Director/Board Member at PROTARA THERAPEUTICS, INC.
Net worth: 4 M $ as of 2024-04-29
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Jesse Shefferman | M | 52 | 7 years | |
| Julian Baker | M | 57 | 23 years | |
| Herve Hoppenot | M | 64 | 10 years | |
| Richard Levy | M | 66 | 19 years | |
| Luke Beshar | M | 65 | 6 years | |
| Jacqueline Zummo | M | 43 | 7 years | |
| Edmund Harrigan | M | 71 | 5 years | |
| Hannah Fry | F | 34 | 4 years | |
| Mary J. Grendell | F | - | - | |
| Thomas Tray | M | 46 | 19 years | |
| Jane Huang | M | 51 | 3 years | |
| Justine O'Malley | M | - | 4 years | |
| Katherine High | M | 72 | 4 years | |
| Cynthia Smith | F | 55 | 3 years | |
| Susanne Antonie Schaffert | M | 57 | 2 years | |
| Sheila Denton | F | 58 | 1 years | |
| Paul Clancy | M | 62 | 9 years | |
| Otis Brawley | M | 64 | 3 years | |
| Pablo Cagnoni | M | 60 | 1 years | |
| Gregory Sargen | M | 59 | 5 years | |
| Roger Garceau | M | 70 | 5 years | |
| Jean-Jacques Bienaimé | M | 70 | 9 years | |
| Michael Solomon | M | 54 | 6 years | |
| Jacqualyn Fouse | M | 62 | 7 years | |
| Paula Swain | F | 66 | 22 years | |
| Peter Langmuir | M | - | 9 years | |
| Denise Brashear | F | - | 2 years | |
| Benjamin J. Strain | M | - | 1 years | |
| D. Coward | M | 59 | 5 years | |
| Kevin Conroy | M | 58 | 5 years | |
| Michael Morrissey | M | - | 8 years | |
| Keith Mikkelson | M | - | 22 years | |
| Vijay Iyengar | M | 51 | 8 years | |
| Christiana Stamoulis | F | 53 | 5 years | |
| Jeffrey Elliott | M | 46 | 5 years | |
| Catalina Loveman | F | - | 9 years | |
| Steven Stein | M | 57 | 9 years | |
| Lothar H. Finke | M | - | 7 years | |
| Patrick Fabbio | M | 56 | 1 years |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Kim Popovits | F | 65 | 17 years | |
| Paul Friedman | M | 81 | 20 years | |
| Henry Fuchs | M | 66 |
Onyx Pharmaceuticals, Inc.
 Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | 10 years |
| Felix Baker | M | 55 | 7 years | |
| Andrew Hindman | M | 51 |
Onyx Pharmaceuticals, Inc.
Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | - |
| Jason W. Radford | M | 42 | 4 years | |
| Ashley Garry | M | - | 1 years | |
| Geoffrey Parker | M | 59 | 3 years | |
| Reid Huber | M | 52 | 16 years | |
| Michael Charles A. Booth | M | 53 | 7 years | |
| Wendy Dixon | M | 68 | 12 years | |
| James J. Vaughn | M | 61 | - | |
| Sriram Ryali | M | 43 |
Onyx Pharmaceuticals, Inc.
Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | 4 years |
| Paul Trower | M | 54 | 18 years | |
| Bryant Lim | M | 53 | 4 years | |
| Krishna Vaddi | M | 58 | 13 years | |
| Andrew Combs | M | 58 | 16 years | |
| Maria Pasquale | F | 58 | 5 years | |
| Blaine Davis | M | 50 | 2 years | |
| David Hastings | M | 62 | 11 years | |
| Suzanne M. Shema | F | 66 |
Onyx Pharmaceuticals, Inc.
Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | - |
| Steven Shak | M | 73 | 19 years | |
| Richard de Schutter | M | 83 | 12 years | |
| Barry Michael Ariko | M | 78 | 14 years | |
| Fred Cohen | M | 67 | 17 years | |
| Paul Brooke | M | 77 | 19 years | |
| Michael Wolfe | M | - |
Onyx Pharmaceuticals, Inc.
Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | 4 years |
| Jathin Bandari | M | 37 | 4 years | |
| Scott Barrett | M | 61 | 3 years | |
| Dashyant Dhanak | M | 63 | - | |
| Kevin N. Heller | M | 53 | 3 years | |
| Frederick Baehner | M | - | - | |
| David Hanlon | M | - | - | |
| Dave Green | M | - | - | |
| Cheng Bonnie | F | - | - | |
| Michael Purvis | M | - | 6 years | |
| Kevin Harris | M | 53 | 10 years | |
| Michael Howell | M | 47 | 4 years | |
| Conrad Jordaan | M | - |
Onyx Pharmaceuticals, Inc.
Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | 3 years |
| Jay Newmark | M | - | 1 years | |
| Richard Bryce | M | 66 |
Onyx Pharmaceuticals, Inc.
Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | 4 years |
| Natalie Sacks | M | 59 |
Onyx Pharmaceuticals, Inc.
Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | 3 years |
| Julio Casoy | M | 72 | 1 years | |
| Gregory W. Schafer | M | 59 |
Onyx Pharmaceuticals, Inc.
Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | 3 years |
| David Gryska | M | 68 | 4 years | |
| Ted Love | M | 65 |
Onyx Pharmaceuticals, Inc.
Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | 2 years |
| Michael Kauffman | M | 60 |
Onyx Pharmaceuticals, Inc.
Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | 1 years |
| Matthew Fust | M | 59 |
Onyx Pharmaceuticals, Inc.
Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | 4 years |
| Kim McEachron | F | 68 | 7 years | |
| Yujiro Hata | M | 49 |
Onyx Pharmaceuticals, Inc.
Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | 3 years |
| Christine K. Chiou | F | - | 4 years | |
| Lucio Tozzi | M | 60 |
Onyx Pharmaceuticals, Inc.
Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | 4 years |
| Robert Newton | M | - | 5 years | |
| Lori Murray | F | - |
Onyx Pharmaceuticals, Inc.
Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | 6 years |
| Barbara Klencke | M | 66 |
Onyx Pharmaceuticals, Inc.
Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | 4 years |
| Jon Cassel | M | - | 12 years | |
| Victor Sandor | M | 57 | 9 years | |
| Todd Edwards | M | 61 | - | |
| William Williams | M | 68 | 11 years | |
| Joseph Leveque | M | 63 |
Onyx Pharmaceuticals, Inc.
Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | 2 years |
| Kristy Rosse | F | - | 3 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| United States | 100 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Barry Flannelly
- Personal Network
